There were 1,673 press releases posted in the last 24 hours and 414,191 in the last 365 days.

North America is Anticipated to Dominate Opioid Overdose Market during the Forecast Period 2022-2030 | Reports and Data

Reports And Data

Reports And Data

The global market for opioid overdose witnessed robust growth in 2021 and is anticipated to grow at a higher revenue CAGR over a forecast period

NEW YORK CITY, NY, UNITED STATES, August 5, 2022 /EINPresswire.com/ -- The Global Opioid Overdose Market report published by Reports and Data is a concise summary on the Opioid Overdose industry and offers deep insights into the industry’s core structure and mechanism. The report digs into the key segments and sub-segments of the industry and offers a thorough study of the industry’s leading regional markets, competitive scenario, product and application segments, technology landscape, sales & distribution networks, and key industry statistics. Market insights included in the report have been compiled through extensive research, detailed market surveys, and expert interviews.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/5231

Largest Market Share:

The North America market is anticipated to dominate market during the forecast period due to increased use of synthetic opioids including fentanyl and its analogs in the U.S. Around two-thirds of opioid-related overdose deaths were reported in 2018 and number of persons dying from opioid overdose increased by 120% between 2010 and 2018. In the U.S., drug overdose mortality increased significantly during COVID-19 epidemic, mostly due to sharp increase in deaths from synthetic opioid overdoses. The market is anticipated to be driven by a growth in number of drug addicts in the North American region and misguided youth who engage in drug misuse and dependency.

Market Dynamics:

The pharma and healthcare sector has significantly advanced in the recent years and is expected to register steady revenue growth over the forecast period owing to rapid innovations in medical technology, increasing investments, rising healthcare expenditure and high adoption of advanced products and systems. Factors such as rising prevalence of chronic diseases such as diabetes, cancer, cardiovascular diseases, and neurological disorders across the globe, rising cases of coronavirus, improving healthcare infrastructure and research facilities, and increasing adoption of remote patient monitoring services and home care settings are expected to fuel global market revenue growth over the forecast period. In addition, increasing number of hospitals and ambulatory care centers worldwide, high demand for personalized medicine, increasing investments in drug discovery and growing investments by public and private sectors are expected to drive global market growth in the coming years.

Competitive Landscape:

The report also focuses on details of each market player including its global position, financial standing, revenue generation, company overview, product & service portfolio. The Opioid Overdose market is extremely competitive and consists of several key players at regional and global level. Key players are focused on adopting various strategies such as new product launches, mergers and acquisitions, investments in R&D, partnerships, joint ventures and collaborations to strengthen their market position and enhance product portfolio.

Leading companies operating in the market are:

Emergent BioSolutions Inc.
SafeRx Pharmaceuticals Inc.
Mucodel Pharma LLC.
Adamis Pharmaceuticals Corporation
Adapt Pharma
Elysium Therapeutics, Inc.
Hepione Therapeutics Inc.
Avior Inc.
Antiop, Inc.
Opiant Pharmaceuticals
Amneal Pharmaceuticals, Inc.
Hikma Pharmaceuticals PLC.

To know more about the report @ https://www.reportsanddata.com/report-detail/opioid-overdose-market

The report also offers detailed insights about market segmentation based on type, application and regional bifurcation:

Opioid Overdose Market Segmentation:

Product Type Outlook (Revenue, USD Billion; 2019-2030)

Solid Dosage Form
Tablet
Capsule
Liquid Dosage Form
Injectable
Nasal Spray

Route of Administration Outlook (Revenue, USD Billion; 2019-2030)

Oral
Parenteral
Intravenous
Intramuscular
Nasal

Regional Outlook:

North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
Italy
France
BENELUX
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
A.E.
South Africa
Rest of MEA

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/5231

Thank you for reading the report. Kindly note that we also offer customized reports according to the client's requirements. Contact us to know more about the customization feature and our team will provide you with the best-customized report.

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Reports And Data | Web: https://www.reportsanddata.com/

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

LinkedIn | Twitter | Blogs

Nikhil Morankar
Reports and Data
+ + 12127101370
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn